International Patent: 5-(1,2,5,6-TETRAHYDROPYRIDIN-3-YL)-1 H-INDAZOLE DERIVATIVES AND SIMILAR COMPOUNDS AS 5-HT2AR ACTIVATORS FOR THE TREATMENT OF NEUROLOGICAL DISEASES

GENEVA, July 31 -- BRANDARIS THERAPEUTICS B.V. filed a patent application (EP2026/051926) for “5-(1,2,5,6-TETRAHYDROPYRIDIN-3-YL)-1 H-INDAZOLE DERIVATIVES AND SIMILAR COMPOUNDS AS 5-HT2AR ACTIVATORS FOR THE TREATMENT OF NEUROLOGICAL DISEASES”. With publication no. WO/2026/159334, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 231/56

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....